IRIS
MINETTO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.679
AS - Asia 478
NA - Nord America 449
Continente sconosciuto - Info sul continente non disponibili 105
SA - Sud America 58
AF - Africa 6
OC - Oceania 3
Totale 4.778
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.576
US - Stati Uniti d'America 408
SG - Singapore 185
CN - Cina 135
VN - Vietnam 81
BR - Brasile 37
FR - Francia 34
BD - Bangladesh 29
FI - Finlandia 22
CA - Canada 19
HK - Hong Kong 12
AR - Argentina 10
DE - Germania 8
IN - India 7
MX - Messico 7
CH - Svizzera 5
GB - Regno Unito 5
IQ - Iraq 5
JP - Giappone 5
TR - Turchia 5
NI - Nicaragua 4
AU - Australia 3
CO - Colombia 3
GR - Grecia 3
ID - Indonesia 3
JM - Giamaica 3
NL - Olanda 3
RU - Federazione Russa 3
VE - Venezuela 3
BE - Belgio 2
CR - Costa Rica 2
DZ - Algeria 2
EC - Ecuador 2
ES - Italia 2
PH - Filippine 2
RO - Romania 2
SI - Slovenia 2
UA - Ucraina 2
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
KR - Corea 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 4.673
Salva come PNG Salva come JPEG
Città #
Genova 1.525
Genoa 1.326
Rapallo 368
Vado Ligure 283
San Jose 101
Singapore 92
Ashburn 57
Beijing 28
Ho Chi Minh City 25
Lauterbourg 23
Helsinki 21
Hanoi 18
Council Bluffs 17
New York 17
Los Angeles 14
Santa Clara 13
Bordighera 11
Hong Kong 11
Frankfurt am Main 7
Toronto 7
Mexico City 6
Phoenix 6
Denver 5
Montreal 5
Rome 5
Washington 5
Haiphong 4
Istanbul 4
Managua 4
Milan 4
Paris 4
Zurich 4
Amsterdam 3
Brooklyn 3
Chicago 3
Da Nang 3
Haidian 3
Lawrenceville 3
Marseille 3
Naples 3
Nardò 3
Newark 3
Orem 3
Perugia 3
Richmond 3
Sydney 3
São Paulo 3
Tokyo 3
Athens 2
Biên Hòa 2
Boardman 2
Bountiful 2
Buffalo 2
Bắc Ninh 2
Cardiff 2
Catania 2
Chesapeake 2
Curitiba 2
Dallas 2
Hewitt 2
Hải Dương 2
Ilion 2
Ljubljana 2
London 2
Madrid 2
Orlando 2
San José 2
Tianjin 2
Trieste 2
Turin 2
Vallejo 2
Vĩnh Long 2
West Bend 2
Aberdeen 1
Acalanes Ridge 1
Algiers 1
Alvorada d'Oeste 1
Amarah 1
Anderson 1
Ankara 1
Apucarana 1
Aracaju 1
Araruama 1
Arima 1
As Sālimīyah 1
Ascurra 1
Atlanta 1
Aurangabad 1
Baghdad 1
Baku 1
Baltimore 1
Bandung 1
Bari 1
Barquisimeto 1
Barranquilla 1
Bathurst 1
Belo Horizonte 1
Bengaluru 1
Bertioga 1
Bethune 1
Totale 4.145
Salva come PNG Salva come JPEG
Nome #
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents 250
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia 227
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 220
Metabolic starvation triggered by l-asparaginase sensitizes multiple myeloma cells to proteasome inhibitors by inducing DNA damage accumulation 217
A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis 215
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas 211
Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives 204
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia 200
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma 200
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes 198
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 188
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 180
Harnessing NK Cells for Cancer Treatment 178
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs 177
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 172
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach 170
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma 170
Chronic graft versus host disease as a weapon for treating chronic myelomonocytic leukemia 166
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 155
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas 153
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 150
SIRT6 inhibition as a novel approach for treating Acute Myeloid Leukemia 133
A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML 119
Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS 101
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation 100
Good tolerability of high dose colistin-based therapy in patients with haematological malignancies 86
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 69
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study 49
The protective role of HCWs communication for the distress of newly diagnosed people with leukemia and lymphoma 43
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group 38
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience 26
Counting the Cost: Anticipated Financial Burden and Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma 13
Totale 4.778
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.569
article - articoli 14.975
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.544
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022311 4 8 22 44 28 28 13 56 26 27 18 37
2022/2023443 38 47 7 41 82 54 2 25 56 28 55 8
2023/2024345 9 27 6 36 22 80 37 74 8 10 18 18
2024/2025835 14 42 21 58 76 99 100 177 23 38 85 102
2025/20261.414 169 36 75 178 176 99 199 52 132 139 78 81
2026/2027128 128 0 0 0 0 0 0 0 0 0 0 0
Totale 4.778